文献速递糖尿病

1型糖尿病过度体重增加对心血管结局的影响:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学(DCCT/EDIC)研究结果

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
PubMed 文献 · Diabetes Care · 2017-01-01

在DCCT/EDIC研究中,1213名1型糖尿病患者的强化治疗(INT)较常规治疗(CONV)减少心血管事件,但体重增加更多。体重增加最高四分位组(Q4 INT)在随访14年后心血管事件曲线显著高于Q1-3 INT组(P=0.024),并与CONV组相似。结论认为前13年INT减少大血管事件,此后Q4 INT组总心血管事件显著增加,需更长期随访。

要点

  • DCCT/EDIC研究中,强化治疗(INT)较常规治疗(CONV)减少心血管事件,但体重增加更多。
  • Q4 INT组体重增加更多且心血管危险因素升高,但总体心血管事件与Q1-3 INT无显著差异。
  • 随访14年后,Q4 INT组心血管事件曲线显著高于Q1-3 INT组(P=0.024),与CONV组相似。

核心结论

  • DCCT后前13年,强化治疗(INT)较常规治疗(CONV)减少大血管事件,即使发生过度体重增加。
  • 此后,Q4 INT组总心血管事件显著增加,与CONV组相当。
  • 需更长期随访以确定该趋势是否持续并导致更多主要心血管事件。

研究设计与样本

  • DCCT/EDIC研究,纳入1213名入组时年龄≥18岁的1型糖尿病患者,按随机治疗组(INT vs. CONV)内体重增加四分位(Q)分组。
  • 使用基线至DCCT结束访视的BMI变化确定体重增加四分位,随后在额外20年观察性随访中评估其对心血管危险因素和结局的影响。

主要发现

  • Q4 INT组较Q1-3 INT组和可比的CONV组有更大比例体重增加(BMI中位变化6.08 kg/m2),心血管危险因素增加,需要高血压和血脂药物治疗。
  • 在平均26年随访中,Q4 INT组与Q1-3 INT组或CONV组相比,主要和总心血管事件数无统计学差异。
  • 至第14年,Q4 INT组的心血管事件曲线显著高于Q1-3 INT组(P=0.024),与CONV组相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需更长期随访以确定该趋势是否持续并导致更多主要心血管事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intensive treatment (INT) of type 1 diabetes reduces the incidence of cardiovascular disease (CVD) events compared with conventional treatment (CONV), but it also results in more weight gain. Our objective was to examine whether excessive weight gain from INT of type 1 diabetes is independently associated with subsequent CVD events. RESEARCH DESIGN AND METHODS: Quartiles (Q) of weight gain in 1,213 participants aged 18 years and older at enrollment in the Diabetes Control and Complications Trial (DCCT) were determined within randomized treatment groups (INT vs. CONV) using change in BMI from baseline to the closeout DCCT visits. Effects of this weight gain on CVD risk factors and outcomes during an additional 20 years of observational follow-up were then determined. RESULTS: The Q4 INT group experienced greater proportional weight gain (median change in BMI, 6.08 kg/m2), increases in CVD risk factors, and need for medications for hypertension and lipids compared with the Q1-3 INT and comparable CONV groups. Over a mean of 26 years of follow-up, the numbers of major and total CVD events were not statistically different in Q4 compared with Q1-3 of either the INT or CONV group. By year 14, however, the incident CVD event curve became significantly higher in the Q4 INT group than in the Q1-3 INT groups (P = 0.024) and was similar to that for the CONV group. CONCLUSIONS: For the first 13 years after DCCT, INT for type 1 diabetes reduced macrovascular events compared with CONV, even when excessive weight gain occurred. After this, total CVD events significantly increased in the Q4 INT group, becoming equivalent to those in the CONV group. Longer follow-up is needed to determine whether this trend continues and results in more major CVD events.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Purnell JQ, Braffett BH, Zinman B, et al. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2017. PMID: 29138273. doi:10.2337/dc16-2523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。